CELVERUM
DEAD

Serial Number

86214771

Owner

Conrad, David

Attorney

Patrick J. Concannon

Filing Date

Mar 7, 2014

Add to watchlist:

No watchlists yet
View on USPTO

CELVERUM Trademark

Serial Number: 86214771 • Registration: 5906003

CELVERUM is a trademark filed by Conrad, David on March 7, 2014. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

Conrad, David (2 trademarks)

122 Shady Oak Lane
Prattville, AL 36066

Entity Type: 01

Trademark Details

Filing Date

March 7, 2014

Registration Date

November 12, 2019

Published for Opposition

August 27, 2019

Cancellation Date

May 22, 2026

Goods & Services

pharmaceutical preparations and substances for the for the treatment of cancer; pharmaceutical preparations and substances for the treatment of immunological, inflammatory and auto-immune conditions, diseases and disorders

scientific and medical research in the field of cancer; scientific and medical research in the field of pharmaceutical and therapeutic products and substances for the treatment of cancer; development of pharmaceutical and therapeutic products and substances for the treatment of cancer; testing and evaluation of pharmaceutical and therapeutic products and substances for the treatment of cancer; scientific and medical research in the field of immunological, inflammatory and auto-immune conditions, diseases and disorders; scientific and medical research in the field of pharmaceutical and therapeutic products and substances for the treatment of immunological, inflammatory and auto-immune conditions, diseases and disorders; development of pharmaceutical and therapeutic products and substances for the treatment of immunological, inflammatory and auto-immune conditions, diseases and disorders; testing and evaluation of pharmaceutical and therapeutic products and substances for the treatment of immunological, inflammatory and auto-immune conditions, diseases and disorders; scientific and medical research in the field of immunological, inflammatory and auto-immune conditions, diseases and disorders

Filing History

CANCELLED SEC. 8 (6-YR)
May 22, 2026 C8..
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Nov 12, 2024 REM1
REGISTERED-PRINCIPAL REGISTER
Nov 12, 2019 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 27, 2019 NPUB
PUBLISHED FOR OPPOSITION
Aug 27, 2019 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 7, 2019 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 22, 2019 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 11, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 11, 2019 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Jul 9, 2019 ERSI
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Apr 5, 2019 GNS2
INQUIRY TO SUSPENSION E-MAILED
Apr 5, 2019 GNSI
SUSPENSION INQUIRY WRITTEN
Apr 5, 2019 CNSI
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Mar 27, 2019 RCCK
ASSIGNED TO LIE
Mar 25, 2019 ALIE
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Sep 7, 2018 RCSC
ASSIGNED TO LIE
Sep 7, 2018 ALIE
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Mar 7, 2018 GNS3
LETTER OF SUSPENSION E-MAILED
Mar 7, 2018 GNSL
SUSPENSION LETTER WRITTEN
Mar 7, 2018 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 27, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 27, 2018 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Feb 22, 2018 ERSI
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Aug 25, 2017 GNS2
INQUIRY TO SUSPENSION E-MAILED
Aug 25, 2017 GNSI
SUSPENSION INQUIRY WRITTEN
Aug 25, 2017 CNSI
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Aug 10, 2017 RCCK
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Feb 6, 2017 GNS3
LETTER OF SUSPENSION E-MAILED
Feb 6, 2017 GNSL
SUSPENSION LETTER WRITTEN
Feb 6, 2017 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 3, 2017 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 3, 2017 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Feb 3, 2017 ERSI
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Feb 3, 2017 GNS2
INQUIRY TO SUSPENSION E-MAILED
Feb 3, 2017 GNSI
SUSPENSION INQUIRY WRITTEN
Feb 3, 2017 CNSI
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Jan 30, 2017 RCCK
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Jul 27, 2016 GNS3
LETTER OF SUSPENSION E-MAILED
Jul 27, 2016 GNSL
SUSPENSION LETTER WRITTEN
Jul 27, 2016 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 22, 2016 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 22, 2016 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Jul 21, 2016 ERSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Feb 5, 2016 GNS3
LETTER OF SUSPENSION E-MAILED
Feb 5, 2016 GNSL
SUSPENSION LETTER WRITTEN
Feb 5, 2016 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 15, 2016 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 15, 2016 CRFA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jan 14, 2016 TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jan 14, 2016 TCCA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Jan 14, 2016 ERSI
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Aug 1, 2015 GNS2
INQUIRY TO SUSPENSION E-MAILED
Aug 1, 2015 GNSI
SUSPENSION INQUIRY WRITTEN
Aug 1, 2015 CNSI
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Jul 29, 2015 RCCK
ASSIGNED TO LIE
Jul 22, 2015 ALIE
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Jan 2, 2015 GNS3
LETTER OF SUSPENSION E-MAILED
Jan 2, 2015 GNSL
SUSPENSION LETTER WRITTEN
Jan 2, 2015 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 30, 2014 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 30, 2014 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 30, 2014 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 30, 2014 GNRN
NON-FINAL ACTION E-MAILED
Dec 30, 2014 GNRT
NON-FINAL ACTION WRITTEN
Dec 30, 2014 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 11, 2014 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 10, 2014 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 10, 2014 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 12, 2014 GNRN
NON-FINAL ACTION E-MAILED
Jun 12, 2014 GNRT
NON-FINAL ACTION WRITTEN
Jun 12, 2014 CNRT
ASSIGNED TO EXAMINER
Jun 12, 2014 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 20, 2014 NWOS
NEW APPLICATION ENTERED
Mar 11, 2014 NWAP